Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis

Table 1 Patient´s characteristic

	ALS	CG	p
Patients, n	54	58	–
ALS onset (limb/bulbar)	40/14	–	–
Gender (male/female)	35/19	32/26	0.338
Age, median (min–max)	62 (40–80)	60 (43–83)	0.120
Diagnostic delay (months)	11.74	–	–
Incidence in the family yes/no	3/51	–	–

The table summarizes the characteristics for ALS patient groups and a healthy control group, including information on the number and proportion of patients, ALS onset, gender, age, familial incidence, and diagnostic delay. The comparison between patients with ALS and control groups revealed no significant differences in terms of age (p = 0.120, independent sample t-test) and gender distribution (p = 0.338, Fisher's exact test). ALS, amyotrophic lateral sclerosis; CG, control group

ISSN: 2047-783X